Neoadjuvant immunotherapy for non-small cell lung cancer: can early intervention result in durable clinical benefit?
Year: 2018
Type: editorial
Abstract: Management of patients with locally advanced non-small cell lung cancer (NSCLC) often relies on multimodality treatment that includes surgical resection in appropriate cases and peri-operative chemotherapy with or without radiation therapy.
Source: Journal of Thoracic Disease
Institutions: National Institutes of Health, National Cancer Institute
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W2888097124
